Last reviewed · How we verify

NCT07414407

Impact of Patient Choice for Epidural Potency on Maternal Satisfaction

Not yet recruiting NA Last updated 17 February 2026
What this trial tests

NA trial testing Patient-selected epidural management in Epidural Analgesia, Obstetric in 150 participants. Not yet recruiting.

Timeline
1 April 2026
Primary endpoint
31 December 2030
31 December 2030

Quick facts

Lead sponsorStanford University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment150
Start date1 April 2026
Primary completion31 December 2030
Estimated completion31 December 2030
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

Adults 18 to 50, female only, with Epidural Analgesia, Obstetric or Maternal Satisfaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial will compare two different approaches to epidural analgesia during labor to see which approach leads to higher patient satisfaction after delivery. Primary aim: determine whether one approach produces greater postpartum maternal satisfaction. Secondary aims: compare pain control and side effects. Participants are people in labor who receive epidural analgesia. They will receive routine clinical epidural care and complete brief, in-hospital questionnaires about pain and satisfaction. All care is provided by the clinical team and safety practices remain unchanged.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07414407.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing